BioSpace News Archive

Business

Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases

Arbor Biotechnologies today announced that it has entered into an agreement with Acuitas Therapeutics, a leader in the development of lipid nanoparticles (LNP).

August 25, 2022
·
3 min read
Drug Development

Elevar Therapeutics Announces Data From Phase 3 Study of Rivoceranib in Combination With Camrelizumab Is Accepted for Late-Breaking Proffered Paper Presentation at ESMO Congress 2022

Elevar Therapeutics, Inc. today announced that initial data from the Phase 3 study of its drug candidate rivoceranib was accepted for a late-breaking proffered paper presentation at the annual Congress of the European Society for Medical Oncology (ESMO) on September 10, 2022 in Paris.

August 25, 2022
·
3 min read
Business

ASLAN Pharmaceuticals Signs License Agreement With Belle.ai to Use belleStudy™ Image Capture Software in Atopic Dermatitis Clinical Trials

BelleTorus Corporation (“Belle.ai”) and ASLAN Pharmaceuticals (Nasdaq: ASLN), today announced that ASLAN has licensed belleStudy™ digital image capture software in support of ASLAN’s clinical trials for atopic dermatitis (AD) across several global sites.

August 25, 2022
·
3 min read
Sharecare to participate in 2022 Wells Fargo Healthcare Conference

Sharecare today announced that it will participate in the 2022 Wells Fargo Healthcare Conference, including a presentation on Wednesday, September 7, 2022 , at 8:35 a.m. E.T.

August 25, 2022
·
1 min read
Pharm Country

Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series

Todos Medical, Ltd. today announced that its Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics, Inc. has enrolled a female Long COVID who was unable to secure MonkeyPox testing while severely symptomatic into diagnostic case study series.

August 25, 2022
·
5 min read
Business

HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer

HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare diseases, today announced the appointment of Brian Wamhoff , PhD, as interim chief executive officer.

August 25, 2022
·
4 min read
Pharm Country

Ordaōs Raises $5 Million in Seed to Accelerate Drug Design and Discovery

Ordaōs today announced the completion of $5M in seed financing to aid in new product development and expand partner acquisition efforts.

August 25, 2022
·
3 min read
Business

Innovent Announced 2022 Interim Results and Business Updates

Innovent Biologics, Inc. announced 2022 interim results and major company updates.

August 25, 2022
·
11 min read
Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™

Longeveron Inc. today announced that the European Patent Office (EPO) has issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to methods to treat endothelial dysfunction.

August 25, 2022
·
6 min read
Business

Wugen Appoints Natalie Mount, Ph.D., as Chair of the Board of Directors

Wugen, Inc. today announced the appointment of biotech executive and cell therapy veteran Natalie Mount, Ph.D., as Chair of the Board of Directors.

August 25, 2022
·
2 min read